Rockefeller Capital Management L.P. Sells 13,970 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rockefeller Capital Management L.P. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 156,717 shares of the medical equipment provider’s stock after selling 13,970 shares during the period. Rockefeller Capital Management L.P.’s holdings in Intuitive Surgical were worth $81,768,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Petros Family Wealth LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $1,081,000. Sterling Capital Management LLC boosted its holdings in Intuitive Surgical by 4.4% in the fourth quarter. Sterling Capital Management LLC now owns 18,577 shares of the medical equipment provider’s stock worth $9,696,000 after acquiring an additional 790 shares in the last quarter. Concorde Asset Management LLC grew its stake in shares of Intuitive Surgical by 21.2% in the fourth quarter. Concorde Asset Management LLC now owns 554 shares of the medical equipment provider’s stock worth $289,000 after acquiring an additional 97 shares during the last quarter. Coign Capital Advisors LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at $651,000. Finally, Heritage Trust Co purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $917,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $493.60 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company’s fifty day simple moving average is $532.72 and its 200-day simple moving average is $532.36. The stock has a market capitalization of $175.81 billion, a PE ratio of 77.00, a P/E/G ratio of 5.85 and a beta of 1.55.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Truist Financial decreased their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday, March 17th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Finally, JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.